Home › Niet-kleincellige longkanker › Virginia › Arlington
Niet-kleincellige longkanker klinische studies in Arlington, VA
104 studies voor Niet-kleincellige longkanker zoeken deelnemers op locaties in en rond Arlington (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
RekruterenFase 2
- Virginia Cancer Specialists - Fairfax /ID# 272004, Fairfax · 11 mijl verwijderd
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
RekruterenFase 3
- Kaiser Permanente Tysons Corner Medical Center, McLean · 5 mijl verwijderd
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
RekruterenFase 1
- Inova Schar Cancer Institute, Fairfax · 11 mijl verwijderd
- NEXT Virginia, Fairfax · 11 mijl verwijderd
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RekruterenFase 1/2
- Virginia Cancer Specialists, Fairfax · 11 mijl verwijderd
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
RekruterenFase 3
- Virginia Cancer Specialists ( Site 0167), Fairfax · 11 mijl verwijderd
A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.
RekruterenFase 2/3
- Virginia Cancer Specialists, PC, Fairfax · 11 mijl verwijderd
A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT-015)
RekruterenFase 3
- Virginia Cancer Specialists ( Site 0114), Fairfax · 11 mijl verwijderd
A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
RekruterenFase 1
- Site 04, Fairfax · 11 mijl verwijderd
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Non-Small Cell Lung Cancer
RekruterenFase 2
- Virginia Cancer Specialists, Fairfax · 11 mijl verwijderd
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
RekruterenFase 1
- ALX Center 2, Fairfax · 11 mijl verwijderd
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
RekruterenFase 3
- Virginia Cancer Specialists, Fairfax · 11 mijl verwijderd
A Study of PHN-012 in Patients With Advanced Solid Tumors
RekruterenFase 1
- PHN-012-001 Site, Fairfax · 11 mijl verwijderd
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
RekruterenFase 3
- Virginia Cancer Specialists, Fairfax · 11 mijl verwijderd
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
RekruterenFase 2
- Virginia Cancer Specialists, Fairfax · 11 mijl verwijderd
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
RekruterenFase 2
- Virginia Cancer Specialists, Fairfax · 11 mijl verwijderd
A Study of Amivantamab and Olomorasib Combination Therapy in Participants With Metastatic Non-Small Cell Lung Cancer
RekruterenFase 1/2
- Virginia Cancer Specialists, Fairfax · 11 mijl verwijderd
A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)
RekruterenFase 1
- Virginia Cancer Specialists PC, Fairfax · 11 mijl verwijderd
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
RekruterenFase 2
- Research Site, Fairfax · 11 mijl verwijderd
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
RekruterenFase 2/3
- Virginia Cancer Specialists - Arlington, Arlington
- Virginia Cancer Specialists, Fairfax · 11 mijl verwijderd
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
RekruterenFase 1/2
- Inova Schar Cancer Institute Clinical Trials, Fairfax · 11 mijl verwijderd
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RekruterenFase 1/2
- NEXT Oncology Virginia, Fairfax · 11 mijl verwijderd
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
RekruterenFase 1
- Virginia Cancer Specialists, Fairfax · 11 mijl verwijderd
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
RekruterenFase 1/2
- Next Oncology Virginia Cancer Specialist, Fairfax · 11 mijl verwijderd
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
RekruterenFase 3
- Research Site, Fairfax · 11 mijl verwijderd
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
RekruterenFase 3
- Clinical Study Site, Fairfax · 11 mijl verwijderd
A Study to Compare Setidegrasib (ASP3082) With Docetaxel, in People With Non-small Cell Lung Cancer With a KRAS G12D Mutation
RekruterenFase 3
- Virginia Cancer Specialists, Arlington
Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
RekruterenFase 3
- Virginia Cancer Specialists, PC, Fairfax · 11 mijl verwijderd
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
RekruterenFase 1
- NEXT - Virginia, Fairfax · 11 mijl verwijderd
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
RekruterenFase 1/2
- NEXT Virginia, Fairfax · 11 mijl verwijderd
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
RekruterenFase 2/3
- Local Institution - 007-814-D, Arlington
- USOR - Virginia Cancer Specialists - Fairfax Office, Fairfax · 11 mijl verwijderd
Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib
RekruterenFase 1/2
- Virginia Cancer Specialists, Fairfax · 11 mijl verwijderd
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
RekruterenFase 1/2
- Inova Schar Cancer Institute, Fairfax · 11 mijl verwijderd
- Next Oncology Virginia, Fairfax · 11 mijl verwijderd
A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)
RekruterenFase 2
- Virginia Cancer Specialists (Fairfax) - USOR, Fairfax · 11 mijl verwijderd
A Phase 1/1b Study of IAM1363 in HER2 Cancers
RekruterenFase 1
- NEXT Oncology - Virginia Cancer Specialists, Fairfax · 11 mijl verwijderd
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
RekruterenFase 1
- USO-Virginia Cancer Specialists, PC, Fairfax · 11 mijl verwijderd
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
RekruterenFase 3
- USO - Virginia Cancer Specialists, Fairfax · 11 mijl verwijderd
A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors
RekruterenFase 1
- NEXT Oncology Virginia, Fairfax · 11 mijl verwijderd
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
RekruterenFase 3
- Research Site, Fairfax · 11 mijl verwijderd
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
RekruterenFase 1
- NEXT Oncology, Fairfax · 11 mijl verwijderd
First-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR or HER2 Exon 20 Insertion Mutations
RekruterenFase 1/2
- NEXT Virginia, Fairfax · 11 mijl verwijderd
A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors
RekruterenFase 1/2
- NEXT Virginia, Fairfax · 11 mijl verwijderd
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
RekruterenFase 1
- Virginia Cancer Specialists, PC, Fairfax · 11 mijl verwijderd
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
RekruterenFase 1
- Virginia Cancer Specialists, Fairfax · 11 mijl verwijderd
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
RekruterenFase 3
- Virginia Cancer Specialists, Fairfax · 11 mijl verwijderd
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
RekruterenFase 1
- NEXT Virginia, Fairfax · 11 mijl verwijderd
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
RekruterenFase 3
- Research Site, Fairfax · 11 mijl verwijderd
Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer
RekruterenFase 2
- Virginia Cancer Specialists, Fairfax · 11 mijl verwijderd
A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
RekruterenFase 1/2
- Virginia Cancer Specialists, Fairfax · 11 mijl verwijderd
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
RekruterenFase 1
- Inova Schar Cancer Institute, Falls Church · 4 mijl verwijderd
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
RekruterenFase 1/2
- Research Site, Fairfax · 11 mijl verwijderd
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
RekruterenFase 3
- Inova Schar Cancer Institute, Fairfax · 11 mijl verwijderd
- Inova Fair Oaks Hospital, Fairfax · 11 mijl verwijderd
A Study of DM005 in Patients With Advanced Solid Tumors
RekruterenFase 1/2
- NEXT Oncology Virginia, Fairfax · 11 mijl verwijderd
A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
RekruterenFase 1/2
- Clinical Trial Site, Fairfax · 11 mijl verwijderd
A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)
RekruterenFase 1/2
- NEXT Virginia, Fairfax · 11 mijl verwijderd
A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations
RekruterenFase 1/2
- NEXT Virginia, Fairfax · 11 mijl verwijderd
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
RekruterenFase 1
- NEXT Oncology - Virginia Cancer Specialists, Fairfax · 11 mijl verwijderd
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
RekruterenFase 1/2
- USOR Virginia Cancer Specialists, Fairfax · 11 mijl verwijderd
Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors
RekruterenFase 1/2
- NEXT Virginia, Fairfax · 11 mijl verwijderd
AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
RekruterenFase 1
- Next Virginia, Fairfax · 11 mijl verwijderd
Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint In
RekruterenFase 3
- Virginia Cancer Specialists, Fairfax · 11 mijl verwijderd
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
RekruterenFase 1
- NEXT Virginia, Fairfax · 11 mijl verwijderd
Clinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-small Cell Lung Cancer
RekruterenFase 1
- NEXT Virginia, Fairfax · 11 mijl verwijderd
Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers
RekruterenFase 1/2
- NEXT Virginia, Fairfax · 11 mijl verwijderd
Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer
RekruterenFase 1
- NEXT Virginia, Fairfax · 11 mijl verwijderd
A Study to Investigate ANS02 in Participants With EGFR Mutation-Positive Non-Small Cell Lung Cancer
RekruterenFase 1/2
- Research Site, Fairfax · 11 mijl verwijderd
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
RekruterenFase 1
- Virginia Cancer Specialists, Fairfax · 11 mijl verwijderd
A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors
RekruterenFase 1
- NEXT Virginia, Fairfax · 11 mijl verwijderd
A Study of Novel Combinations in Non-Small Cell Lung Cancer (NSCLC)
RekruterenFase 2
- Research Site, Fairfax · 11 mijl verwijderd
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
RekruterenFase 1/2
- NEXT Oncology Virginia, Fairfax · 11 mijl verwijderd
A Study of LY4175408 in Participants With Advanced Cancer
RekruterenFase 1
- NEXT Virginia, Fairfax · 11 mijl verwijderd
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
RekruterenFase 1
- Virginia Cancer Specialists - Fairfax /ID# 232592, Fairfax · 11 mijl verwijderd
Study of XB010 in Subjects With Solid Tumors
RekruterenFase 1
- Inova Schar Cancer, Fairfax · 11 mijl verwijderd
- NEXT Virginia, Fairfax · 11 mijl verwijderd
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
RekruterenFase 1
- NEXT Texas LLC - Virginia, Fairfax · 11 mijl verwijderd
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
RekruterenFase 1
- NEXT Virginia, Fairfax · 11 mijl verwijderd
First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
RekruterenFase 1
- Research Site, Fairfax · 11 mijl verwijderd
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
RekruterenFase 1
- Research Site, Fairfax · 11 mijl verwijderd
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
RekruterenFase 2
- Kaiser Permanente Tysons Corner Medical Center, McLean · 5 mijl verwijderd
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
RekruterenFase 1
- NEXT Oncology Virginia, Fairfax · 11 mijl verwijderd
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
RekruterenFase 1/2
- NEXT Virginia, Fairfax · 11 mijl verwijderd
Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)
RekruterenFase 3
- Virginia Cancer Specialists, Fairfax · 11 mijl verwijderd
Dose Escalation/Expansion Study of Mavrostobart (PT199), an Anti-CD73 mAb, Administered Alone and in Combination With a PD-1 Inhibitor or Chemotherapy (the MORNINGSTAR Study)
RekruterenFase 1/2
- NEXT Oncology, Fairfax · 11 mijl verwijderd
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
RekruterenFase 1
- NEXT Oncology Virginia, Fairfax · 11 mijl verwijderd
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
RekruterenFase 1/2
- Next Oncology Virginia, Fairfax · 11 mijl verwijderd
A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
RekruterenFase 3
- Research Site, Fairfax · 11 mijl verwijderd
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
RekruterenFase 2/3
- Kaiser Permanente Tysons Corner Medical Center, McLean · 5 mijl verwijderd
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
RekruterenFase 2
- Kaiser Permanente Tysons Corner Medical Center, McLean · 5 mijl verwijderd
A Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers With Advanced Lung Adenocarcinoma
RekruterenFase 2
- Inova Fairfax Hospital, Fairfax · 11 mijl verwijderd
A 2-part Phase 1/2 Open-label Trial on ODM-212
RekruterenFase 1/2
- NEXT Oncology Virginia, Fairfax · 11 mijl verwijderd
A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
RekruterenFase 1/2
- NEXT Virginia, Fairfax · 11 mijl verwijderd
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
RekruterenFase 1/2
- Virginia Cancer Specialists, Fairfax · 11 mijl verwijderd
Phase Ib Study of the Safety of T-DXd and Immunotherapy Agents With and Without Chemotherapy in Advanced or Metastatic HER2+, Non-squamous NSCLC
RekruterenFase 1
- Research Site, Fairfax · 11 mijl verwijderd
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
RekruterenFase 1/2
- NEXT Virginia, Fairfax · 11 mijl verwijderd
A Study of DB-1310 in Advanced/Metastatic Solid Tumors
RekruterenFase 1/2
- NEXT Virginia, Fairfax · 11 mijl verwijderd
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
RekruterenFase 1
- NEXT Virginia, Fairfax · 11 mijl verwijderd
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
RekruterenFase 1/2
- Virginia Cancer Specialists, Fairfax · 11 mijl verwijderd
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
RekruterenFase 1/2
- NEXT Virginia, Fairfax · 11 mijl verwijderd
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
RekruterenFase 1/2
- NEXT, Virginia, Fairfax · 11 mijl verwijderd
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
RekruterenFase 1
- Dren Investigational Site, Fairfax · 11 mijl verwijderd
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
RekruterenFase 1
- Virginia Cancer Specialists, Fairfax · 11 mijl verwijderd
Study to Evaluate LB-LR1109, Administered Alone for the Treatment of Solid Tumor and in Combination With Atezolizumab for the Treatment of NSCLC
RekruterenFase 1
- NEXT Oncology, Fairfax · 11 mijl verwijderd
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
RekruterenFase 1/2
- Research Site 102, Fairfax · 11 mijl verwijderd
- Research Site 112, Fairfax · 11 mijl verwijderd
A Study to Assess the Efficacy of WSD0922-FU in Patients With C797S+ Advanced Non-small Cell Lung Cancer
RekruterenFase 2
- Virginia Cancer Specialists, Fairfax · 11 mijl verwijderd
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
RekruterenFase 1/2
- Virginia Cancer Specialists, Fairfax · 11 mijl verwijderd
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
RekruterenFase 1/2
- NEXT Virginia, Fairfax · 11 mijl verwijderd
Niet-kleincellige longkanker studies in andere steden
- Houston, TX145 studies
- New York City, NY121 studies
- Nashville, TN97 studies
- Boston, MA90 studies
- Los Angeles, CA87 studies
- St. Louis, MO73 studies
- Chicago, IL61 studies
- Baltimore, MD60 studies
- San Antonio, TX59 studies
- Columbus, OH57 studies
- Washington, DC55 studies
- Seattle, WA53 studies
Andere studies in Arlington
- Metastatische kanker53 studies
- Colorectale kanker52 studies
- Kanker (alle vormen)48 studies
- Borstkanker47 studies
- Eierstokkanker46 studies
- Longkanker41 studies
- Endometriumkanker39 studies
- Aldermeesklierkanker33 studies
- Plaveiselcelcarcinoom van hoofd en hals26 studies
- Kleincellige longkanker23 studies
- Maagkanker20 studies
- Drievoudig negatieve borstkanker20 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.